William Jeffery Edenfield

6PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersInstrumental methods (excl. immunological and bioassay methods)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 27, 2026
Metabolic Signatures of Breast Cancer Subtypes and the Metabolic Impact of Chemotherapy.

Aubrey Mattingly, Zoe Vickery, Alex Fiorentino

|Jun 27, 2024
Correlation Analysis of Genetic Mutations and Galectin Levels in Breast Cancer Patients.

Ella G Markalunas, David H Arnold, Avery T Funkhouser

|Mar 28, 2024
Exploratory Assessment of Galectin-1, -3, and -9 in Non-Small Cell Lung Cancer.

Hayden Shuster, Avery Funkhouser, Lorie Allen

|Jul 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.

Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson

|Apr 24, 2021
A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers.

William Jeffery Edenfield, Ki Chung, Mark O'Rourke

Pageof 1